Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM

NCT01526694 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bendamustine
DRUG: Thalidomide
DRUG: Dexamethasone

Sponsor

Azienda Ospedaliera di Bolzano

Collaborators

[object Object]